Gaviscon, mint suspension, 300ml

Product description

Gaviscon®, oral suspension [peppermint]. When taken orally, Gaviscon ® forms a protective barrier on the surface of the stomach contents, preventing acid from flowing from the stomach to the esophagus for up to four hours. A reduction in irritation is felt 3-4 minutes after ingestion. The mechanism of action of the active substances of Gaviscon® is physical and does not depend on absorption into the systemic circulation.

Composition

>

of 10 ml of suspension contains:

Active ingredients:

sodium alginate 500 mg;

sodium bicarbonate;

calcium carbonate;

Auxiliary substances:

carbomer;

methyl parahydroxybenzoate;

propyl parahydroxybenzoate;

sodium saccharinate;

peppermint oil;

sodium hydroxide;

purified water.

Pharmacological action

Gaviscon® enters the stomach and interacts with its contents, forming a protective barrier (raft) that prevents the occurrence of heartburn.

Gaviscon is an antacid.

Pharmacodynamics

When taken orally, Gaviscon reacts quickly with acidic stomach contents. In this case, an alginate gel is formed, which prevents the occurrence of gastroesophageal reflux. During regurgitation, the gel is more likely than the contents of the stomach to enter the esophagus, where it reduces irritation of the mucous membrane.

Pharmacokinetics

The mechanism of action of the drug Gaviscon does not depend on absorption into the systemic circulation.

Indications

Symptomatic treatment of dyspepsia associated with increased acidity of gastric juice and gastroesophageal reflux (heartburn, acid belching) ; feeling of heaviness in the stomach after eating, including during pregnancy.

Use during pregnancy and lactation

Gaviscon can be used during pregnancy and lactation.

Contraindications

Hypersensitivity to the components of the drug; children under 6 years of age.

Side effects

Possible allergic reactions.

How to take, course of use and dosage

Inside, after meals and before going to bed.

Adults and children over 12 years of age — 10-20 ml each. The maximum daily dose is 80 ml.

Children 6-12 years — 5-10 ml. The maximum daily dose is 40 ml.

For older patients, no dose adjustment is required.

Overdose

Symptoms:  bloating may occur.

Treatment:  symptomatic therapy.

Description

Gaviscon® enters the stomach and interacts with its contents, forming a protective barrier (raft) that prevents the occurrence of heartburn.

Special instructions

In 10 ml of suspension, the sodium content is 141 mg (6.2 mmol). This should be taken into account if a diet with a limited salt content is necessary, for example in some cases of congestive heart failure and kidney function disorders.

If there is no improvement in symptoms within 7 days, you should consult your doctor.

Form of production

Suspension for oral use.

Storage conditions

Store at a temperature of 15 °C to 25 °C. Keep out of reach of children.

Shelf life

3 years

Active ingredient

Sodium Alginate, Sodium Bicarbonate, Calcium Carbonate

Dosage form

suspension for oral use

Description

For adults, Pregnant women, Children over 12 years of age, Nursing mothers

Indications

Heartburn, Gastritis, Gastric and Duodenal Ulcers, Reflux Esophagitis